Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Carter

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
The Australian and New Zealand Journal of Psychiatry|January 22, 2005
Assessing cost-effectiveness of drug interventions for schizophreniaAnne Magnus, Vaughan Carr, Cathrine Mihalopoulos, et al.
MDM Policy & Practice|June 14, 2019
A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016Anne Magnus, Wanrudee Isaranuwatchai, Cathrine Mihalopoulos, et al.
Stroke|February 3, 2009
Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS)Dominique A Cadilhac, Rob Carter, Amanda G Thrift, et al.
Heart, Lung & Circulation|November 21, 2013
Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's indigenous populationKatherine S Ong, Rob Carter, Theo Vos, et al.
Social Science & Medicine (1982)|December 5, 2006
Priority setting in health care using multi-attribute utility theory and programme budgeting and marginal analysis (PBMA)Stuart J Peacock, Jeff R J Richardson, Rob Carter, et al.
The Australian and New Zealand Journal of Psychiatry|August 10, 2004
Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorderMarie Donnelly, Michelle M Haby, Rob Carter, et al.
The Australian and New Zealand Journal of Psychiatry|July 30, 2005
Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depressionTheo Vos, Justine Corry, Michelle M Haby, et al.
Stroke|February 25, 2012
Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective?Dominique A Cadilhac, Rob Carter, Amanda G Thrift, et al.
The Australian and New Zealand Journal of Psychiatry|August 10, 2004
Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescentsMichelle M Haby, Bruce Tonge, Lyn Littlefield, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Priority setting in health: origins, description and application of the Australian Assessing Cost-Effectiveness initiativeRob Carter, Theo Vos, Marj Moodie, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
The Australian and New Zealand Journal of Psychiatry|January 22, 2005
Assessing cost-effectiveness of drug interventions for schizophreniaAnne Magnus, Vaughan Carr, Cathrine Mihalopoulos, et al.
MDM Policy & Practice|June 14, 2019
A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016Anne Magnus, Wanrudee Isaranuwatchai, Cathrine Mihalopoulos, et al.
Stroke|February 3, 2009
Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS)Dominique A Cadilhac, Rob Carter, Amanda G Thrift, et al.
Heart, Lung & Circulation|November 21, 2013
Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's indigenous populationKatherine S Ong, Rob Carter, Theo Vos, et al.
Social Science & Medicine (1982)|December 5, 2006
Priority setting in health care using multi-attribute utility theory and programme budgeting and marginal analysis (PBMA)Stuart J Peacock, Jeff R J Richardson, Rob Carter, et al.
The Australian and New Zealand Journal of Psychiatry|August 10, 2004
Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorderMarie Donnelly, Michelle M Haby, Rob Carter, et al.
The Australian and New Zealand Journal of Psychiatry|July 30, 2005
Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depressionTheo Vos, Justine Corry, Michelle M Haby, et al.
Stroke|February 25, 2012
Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective?Dominique A Cadilhac, Rob Carter, Amanda G Thrift, et al.
The Australian and New Zealand Journal of Psychiatry|August 10, 2004
Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescentsMichelle M Haby, Bruce Tonge, Lyn Littlefield, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Priority setting in health: origins, description and application of the Australian Assessing Cost-Effectiveness initiativeRob Carter, Theo Vos, Marj Moodie, et al.
Pageof 11